本期信息
于报告期内（截至2025年9月30日止六个月）营收约1,050万港元，同比增长0.6%，主要来自综合性医院服务。本期毛利率为79.37%，上年同期为78.40%。
经调整后净亏损为267万港元，而上年同期经调整后净亏损为286万港元，实现亏损收窄。上年同期扣除一次性处置子公司收益后，亏损口径变动主要源于销售及分销开支明显增长66.69%，但行政开支同比减少7.79%。
经营活动产生的现金流由上年同期的约480万港元转为本期净流出约1,446万港元，主要因报告期内整体经营投入增加所致。
业务分项
公司收入仍主要来自综合性医院服务板块。本期该板块收入约1,050万港元，占总营收全部，较上年同期（扣除处置因素影响后）保持稳定。
高管解读
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.